Experts Preview Practice-Changing Data Ahead of 2026 ASCO GU?
Oncologists highlight key 2026 ASCO GU studies in bladder, prostate, kidney and testicular cancers that could reshape treatment and personalize care.
Article LinkWhat Is on the Horizon for Kidney Cancer?
Kidney cancer treatment is evolving rapidly with new targeted therapies, immunotherapies, and clinical research shaping the future of care.
Article LinkTop 3 Takeaways From ASCO GU 2025
Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium
Article LinkGene Variant May Predict Side Effects From Kidney Cancer Immunotherapy
A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy.
Article LinkInvestigating Quality of Life and Treatment Adherence in Kidney Cancer
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Article LinkAssoc. Prof. Dr. Emre Yekedüz Awarded the “Merit Award"
Our faculty member, Assoc. Prof. Dr. Emre Yekedüz from the Department of Medical Oncology, who continues his research as a researcher at Harvard University and the Dana-Farber Cancer Institute in Boston, United States, has been awarded the “Merit Award,” which is presented to the best scientific presentations.
Read Article LinkA Significant International Scientific Achievement by Assoc. Prof. Dr. Emre Yekedüz
Assoc. Prof. Dr. Emre Yekedüz’s article titled “Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2,” based on his work conducted at Harvard University during an overseas assignment, has been published in the journal Clinical Cancer Research.
Read Article LinkThe Current State of Renal Oncology in Turkey
An overview of renal cancer epidemiology and management practices in Turkey. Challenges and innovations shaping renal oncology care within the region. Insights from ongoing clinical research and therapeutic developments. Prospects for collaboration and future advancements in Turkish renal oncology. With a strong commitment to clinical excellence and research, Dr. Yekedüz highlights a focused and region-specific perspective aiming to elevate renal cancer care and research
ReadAvrupa Medikal Onkoloji Derneği'nin 2023 Madrid Toplantısı
Avrupa Medikal Onkoloji Derneği'nin 2023 Madrid Toplantısı
Watch the VideoOncology Experts Preview Top Abstracts From the 2024 ESMO Congress
Experts from across oncology specialties discuss the abstracts and presentations they are most looking forward to seeing at the 2024 ESMO Congress.
Listen the PodcastsLet’s talk or book now
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel facilisis.
